Fundz

KKR to acquire majority stake in HealthCare Royalty

PUBLIC · KKRAug 15, 2025

Acquiring Company

Kohlberg Kravis Roberts

Acquired Company

HealthCare Royalty Partners

New YorkConnecticutEnergyFinancial ServicesReal EstateFinanceReal Estate InvestmentVenture CapitalAngel InvestmentRenewables & EnvironmentBiotechnologyHealth CareVenture Capital

Description

KKR has successfully acquired a majority stake in HealthCare Royalty Partners. This acquisition strengthens KKR's position in the healthcare investment space and provides increased capital to HealthCare Royalty. The partnership aims to foster growth in the healthcare sector, enhancing innovation. Both companies are expected to benefit from this strategic deal.

Other recent acquisitions in Energy and Financial Services

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Kohlberg Kravis Roberts, and when

When Kohlberg Kravis Roberts changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Kohlberg Kravis Roberts raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kohlberg Kravis Roberts, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kohlberg Kravis Roberts. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kohlberg Kravis Roberts

Location

New York, New York, United States

About

Kohlberg Kravis Roberts (KKR) is a leading global investment firm that manages multiple asset classes, including private equity, energy, infrastructure, real estate, and credit. Founded in 1976, KKR has a long history of investing in companies across various sectors. The firm focuses on delivering value to its investors through active management and strategic growth initiatives.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kohlberg Kravis Roberts makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Chris
Likely contact at this company
••••••••@••••••••

See Chris's verified email →

Akshay
Senior decision-maker at this company
••••••••@••••••••

See Akshay's verified email →

Pradeep
Senior decision-maker at this company
••••••••@••••••••

See Pradeep's verified email →

Christopher
Likely contact at this company
••••••••@••••••••

See Christopher's verified email →

Tisha
Likely contact at this company
••••••••@••••••••

See Tisha's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Kohlberg Kravis Roberts's next move

Learn about Strategic plan

Frequently asked

Who acquired HealthCare Royalty Partners?

HealthCare Royalty Partners was acquired by Kohlberg Kravis Roberts, based in New York. The deal was reported on August 15, 2025. Kohlberg Kravis Roberts (KKR) is a leading global investment firm that manages multiple asset classes, including private equity, energy, infrastructure, real estate, and credit. Kohlberg Kravis Roberts is publicly traded (KKR) and operates in Energy.

When did Kohlberg Kravis Roberts acquire HealthCare Royalty Partners?

Kohlberg Kravis Roberts's acquisition of HealthCare Royalty Partners was reported on August 15, 2025. KKR has successfully acquired a majority stake in HealthCare Royalty Partners. This acquisition strengthens KKR's position in the healthcare investment space and provides increased capital to HealthCare Royalty. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does HealthCare Royalty Partners do?

HealthCare Royalty Partners is a leading investment firm focused on the healthcare industry, specializing in royalty investments. Founded in 2008, it provides capital to healthcare companies by investing in royalties on approved drugs and therapies. It is privately held, operating in Biotechnology, and is based in Connecticut.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.